Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001689548-22-000111
Filing Date
2022-08-08
Accepted
2022-08-08 16:07:39
Documents
59
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q prax-20220630.htm   iXBRL 10-Q 1487008
2 EX-31.1 exhibit31120220630.htm EX-31.1 13130
3 EX-31.2 exhibit31220220630.htm EX-31.2 14449
4 EX-32.1 exhibit32120220630.htm EX-32.1 13431
  Complete submission text file 0001689548-22-000111.txt   5220872

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prax-20220630.xsd EX-101.SCH 29413
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prax-20220630_cal.xml EX-101.CAL 49950
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prax-20220630_def.xml EX-101.DEF 137848
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prax-20220630_lab.xml EX-101.LAB 416425
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prax-20220630_pre.xml EX-101.PRE 257901
53 EXTRACTED XBRL INSTANCE DOCUMENT prax-20220630_htm.xml XML 738243
Mailing Address 99 HIGH STREET, 30TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET, 30TH FLOOR BOSTON MA 02110 617-300-8460
Praxis Precision Medicines, Inc. (Filer) CIK: 0001689548 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39620 | Film No.: 221144382
SIC: 2834 Pharmaceutical Preparations